Results 111 to 120 of about 54,678 (274)

Effects of EZH2 on macrophage cholesterol accumulation and aortic plaque.

open access: yes, 2016
A, EZH2 enhanced cholesterol accumulation in THP-1 and RAW264.7 macrophage-derived foam cells. THP-1/RAW264.7 macrophages were stained for lipids with Oil red O. The nuclei were stained with hematoxylin.
Yan-Yan Tang (463145)   +16 more
core   +1 more source

Genomics and epigenomics of tissue repair: Implications for personalized medicine

open access: yesPrecision Medical Sciences, EarlyView.
Genomic and epigenomic mechanisms govern tissue repair and regeneration through dynamic regulation of inflammation, cell fate, and extracellular matrix remodeling. The integration of multi‐omics, artificial intelligence, and precision regenerative therapies enables biomarker‐driven, personalized approaches to enhance healing and minimize fibrosis ...
Jharna Medhi   +7 more
wiley   +1 more source

Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia

open access: yesMolecular & Cellular Oncology, 2017
The polycomb protein enhancer of zeste homolog 2 (EZH2) may have a dual role in cancer pathogenesis acting as an oncogene or as a tumor suppressor depending on the cancer type.
Stefanie Göllner, Carsten Müller-Tidow
doaj   +1 more source

EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth [PDF]

open access: yes
Breast cancer (BC) remains the second leading cause of cancer-related mortalities in women. Resistance to hormone therapies such as tamoxifen, an estrogen receptor (ER) inhibitor, is a major hurdle in the treatment of BC.
Cai, Ling   +4 more
core   +1 more source

Artificial intelligence empowers targeted protein degradation: Core technological innovations, multi‐scenario applications, and translational prospects

open access: yesSmart Molecules, EarlyView.
AI is transforming TPD by improving the design, prediction, and optimization of degraders such as PROTACs, molecular glues, and LYTACs. This review summarizes key AI‐driven advances, highlights applications across drug discovery stages, and discusses remaining challenges and future directions for accelerating the development of therapies against ...
Shuanglin Qin   +10 more
wiley   +1 more source

Regulation of Tumor Angiogenesis by EZH2

open access: yes, 2012
[[abstract]]"Although VEGF-targeted therapies are showing promise, new angiogenesis targets are needed to make additional gains. Here, we show that increased Zeste homolog 2 (EZH2) expression in either tumor cells or in tumor vasculature is predictive of
;Lu, C.;Han, H.D.;Mangala, L.S.;Ali-Fehmi, R.;Newton, C.;Ozbun, L;Armaiz-Pena, G.;Hu, W.;Stone, R;Munkarah, A;Ravoori, M.K.;Shahzad, M.;Lee, J.W.;Mora.E.;Langley, R.R.;Carroll, A.R.;Matsuo, K.;Spannuth, W.A.;Schmandt, R.;Jennings, N.B;Goodman, B.W.;Jaffe, R.B.;Nick, A.M.;Kim, H.S.;Guven, E.O.;Chen, Y.H.;李龍緣;Li, Long-Yuan;Hsu, M.C.;Coleman, R.L.;Calin, G.A.;Denkbas, E.B.;Lim, J.Y.;Lee, J.S.;Kundra, V.;Birrer, M.J;洪明奇;Hung, Mien-Chie;Lopez-Berestein, G;Sood, A,K.
core  

Integrative Bioinformatics, Experimental Validation, and Interpretable Machine Learning Reveal Oxyresveratrol‐Mediated Protection Against Cadmium‐Induced Lung Adenocarcinoma‐Related Transcriptional Dysregulation

open access: yesEnvironmental Toxicology, EarlyView.
ABSTRACT Cadmium (Cd) is a toxic heavy metal strongly implicated in lung adenocarcinoma (LUAD) through mechanisms involving oxidative stress, epigenetic dysregulation, and chronic inflammation. This study aimed to identify Cd‐responsive genes associated with LUAD and to evaluate the protective effects of oxyresveratrol (O‐RES) against Cd‐induced ...
Murat Isıyel, Hamid Ceylan, Yeliz Demir
wiley   +1 more source

Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients

open access: yesBritish Journal of Haematology, EarlyView.
Summary Myelodysplastic neoplasms (formerly myelodysplastic syndromes, MDS) are heterogeneous clonal haematological malignancies that primarily affect the elderly, though a notable proportion of patients are diagnosed at younger ages. We retrospectively analysed 1437 patients diagnosed or treated at Asan Medical Center between 1989 and 2022, comparing ...
Hyunkyung Park   +15 more
wiley   +1 more source

COMPARISON OF EZH2, BCL-2, BER-EP4, AND CK20 EXPRESSION WITH THE KI67 PROLIFERATIVE INDEX AND OTHER ADVERSE CLINICAL INDICATORS, AND COMPARISON OF EXPRESSION WITH THE MORPHOLOGICAL TYPE OF BASAL CELL CARCINOMA [PDF]

open access: yesJournal of IMAB
Introduction: Basal cell carcinoma (BCC) is the most common cutaneous malignant tumor, characterized by locally invasive growth and low metastatic potential. The role of immunohistochemical markers such as EZH2, Bcl-2, Ber-EP4, and Ki67 in the assessment
Boyana Anatolieva   +2 more
doaj   +1 more source

Identification of a Novel <i>KRAS::ETNK1</i> Fusion Transcript in a Myelodysplastic/Myeloproliferative Overlap Syndrome With Eosinophilia: A Case Report. [PDF]

open access: yesEJHaem
ABSTRACT This work describes, to our knowledge, the first reported case of a patient with an MDS/MPN overlap syndrome harboring a novel KRAS::ETNK1 fusion transcript. The disease initially presented with eosinophilia, megakaryocyte expansion, mast cell infiltration, and a background of typical MDS/MPN‐associated mutations (ASXL1, TET2, EZH2, BCOR, and ...
Caledec M   +17 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy